the obvious, page-5

Yes.
My understanding is that most long term shareholders fully understand the value proposition.
The website opening statement makes that clear now....mass production of GMP low cost MCS's is ours and only ours and nearly all regen therapy companies willl need what we have,,and have to pay!!( read unbelievable value gap)
Had the company employed a few more people on both the promotional front and the license partner front we would be in excess of 100 mill now.Maybe less money in the bank but who cares when the SP is up.
I guess when you have a super massive stem cell black whole land in your lap..there may be a reluctance to have others come in and steal thunder...
That clearly has to change now. either thru an LOI being converted into a science validating deal ( catapulting awareness) or reasonable shareholder request.